Training & Education

TRAINING MODULES
MRCT Center Virtual Training

View all MRCT Center virtual training modules here:

Training & Education

The skills and experience of investigators and study staff, research ethics boards, and regulators vary widely across the globe. To meet the demands of the changing regulatory and ethics landscape, regulators, ethics committees, Investigators, and site staff need continuous learning and discussion of emerging issues in clinical research. Training and capacity building is one of the core strengths of the MRCT Center.

Long-standing history in capacity building

The MRCT Center has a long-standing history of developing ethics and regulatory skills in both high and low- and middle-income countries. The MRCT Center has been endorsed by the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) as a training associate and designated as an Asia-Pacific Economic Cooperation (APEC) Training Center of Excellence. Over the past decade, our capacity building efforts have trained more than 10,000 participants from over 100 countries and spanned from data monitoring committees, pharmacovigilance and safety, clinical research professional competency, good clinical practice and multi-regional clinical trials, to research ethics.

Approach to capacity building and training

Since 2020, the MRCT Center has leveraged technical capabilities to develop both virtual and sustainable online training.

In-person or in-country training: in-person / in-country dynamic training using a training model in which we partner with a local collaborator (e.g., academic leader, regulator, institution) to identify the appropriate topics that are of highest need and select the trainees for the course

Online, recorded training modules: available free of charge on an MRCT Center portal within the Mass General Brigham Office of Continuing Professional Development website. 

Virtual training: live, interactive training sessions delivered virtually, in collaboration with an in-country partner


Areas of Expertise:

The MRCT Center has expertise in the following areas:

  • ICH Guidelines: As a Training Associate of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH), the MRCT Center is working with ICH to develop a series of training modules:
    • General Considerations for Clinical Trials E8(R1): The E8(R1) Introductory Overview Video is available on the ICH Training Library website. A series of in-depth training modules for ICH E8(R1) with case studies and interactive learning activities is in development.
    • Good Clinical Practice E6(R3): The MRCT Center is working closely with the E6(R3) Expert Working Group (EWG) to develop a series of in-depth training modules for the revised Good Clinical Practice (GCP) guidelines. The first set of modules has been released in October 2025.
    • General Principles for Planning and Design of Multi-Regional Clinical Trials E17: A landscape analysis of implementation issues with ICH E17 is in development.
  • Clinical Research and Ethics: The MRCT Center is building capacity for research ethics committees (RECs) across Africa and worldwide. Our work aims to harmonize the clinical trial application review process and build a robust, competent, and efficient system for the ethics review of clinical research.  The online, on-demand training course entitled “Ethics and Review of Interventional Clinical Research” is freely available on the WHO Academy. Development for the second course in the series “Ethics and Review of Interventional Clinical Research” is ongoing and anticipated to be available in the fall of 2025.
  • Clinical Research Design and Conduct: The MRCT Center designed a curriculum to introduce the audience to the process of drug development and clinical research, including research and development, bioethics, good clinical practice, regulatory requirements, as well as post-market surveillance and real-world evidence. The MRCT Center collaborates with partners to design the curriculum specific to the audience as well as the local regional context. Example: Virtual clinical research training in Indonesia.
  • Data Monitoring Committee Training: Recognizing the need for greater engagement from emerging economies, the MRCT Center created a training program to engage motivated individuals to become Data Monitoring Committee (DMC) champions within their home country and to participate in DMCs for multi-regional clinical trials. Example: Virtual DSMC Training in the Philippines.
  • Health Literacy: Online, virtual, and in-person capacity building activities provide research professionals with practical guidance and tools to integrate health literacy best practices into their roles. For Example: IRB Health Literacy in Clinical Research online training.
  • Representation in Clinical Research: The MRCT Center training is intended to aid attendees in improving their ability to enroll underrepresented participants in clinical research and develop mechanisms for ongoing sustainability of representative populations in clinical research. For more information: Equity by Design 6-part virtual training course.
  • Causality Training:  This training enables clinicians and ethics committee members to follow best practice procedures in determining causality for participant injuries or illnesses occurring in the course of a clinical trial. Example: Causality Assessment Workshop in Gurgeon, India.

OBJECTIVES

  • Improve regulatory capacity to provide a unified standard for conducting and oversight of clinical trials
  • Improve capacity of those planning and reviewing clinical trials to conduct effective multi-regional trials
  • Improve capacity of those planning, reviewing, and conducting clinical trials to ultimately lead to participant safety

project Leadership & sTAFF

  • Barbara Bierer, MD. Faculty Director, MRCT Center
  • Sarah White, MPH. Executive Director, MRCT Center
  • Carmen Aldinger, PhD, MPH, PMP. Senior Administrative and Training Manager, MRCT Center
  • Chloe de Campos, BS. Graphics and Information Design Specialist, MRCT Center
  • Lauren Otterman, MBE. Project Manager, MRCT Center

Project Resources

Global Regulatory Engagement

Global Regulatory Engagement

Regulatory issues in different countries and in different regions of the world impact the conduct, efficiency, and oversight of clinical trials.  Our approach has been to work with representatives of the global clinical trial ecosystem to identify major issues in international clinical trial practice. We strive to promote a country-specific and culturally relevant approach.

In today’s global environment, there are numerous challenges to expanding clinical research sites globally, such as differing regulations and processes, variability in staff availability and training, inadequate hospital/clinical sites and laboratories, lack of supply chain infrastructure, concerns related to drug shipping/storage, currency devaluation, and governmental instability. Collaborative and harmonized efforts are critical for building capacity in clinical research in these new geographic regions. There is a need for targeted engagement with regulators, national ethics committees, and influential thought leaders to develop trusted partnerships with a shared mission of improving the ethics, design, conduct, and oversight of multi-regional clinical trials. The MRCT Center is working with diverse stakeholders to advance clinical research in new geographic regions, including Africa, the Middle East, Southeast Asia, and Latin America.

Objectives

  • Work closely with in-country leaders to determine tractable solutions to regulatory reform issues and ethics review
  • Collaborate with clinical trial stakeholders to understand and harmonize efforts to build capacity in clinical research
  • Build individual and systems capacity for regulatory and ethics review, cooperation, and reliance
  • Help establish sustainable infrastructure, operations, and expertise to enable training and continuous learning

Building Capacity for Ethics Review of Clinical Research Across Africa

Collaborating with international and local organizations to build capacity for research ethics committees across Africa and worldwide. For more information, click here.


Building Capacity for innovative multi-country clinical trials in South-East Asia

The MRCT Center has worked together with academic institutions in South Korea to build capacity for clinical trials for more than a decade. For half a decade, the MRCT Center has collaborated on an innovative approach to setting up a three-country study in South-East Asia involving integrative therapies with a common endpoint. The MRCT Center developed a self-monitoring toolkit and provides recommendations on study design and expert guidance to support optimal study conduct.

Key Milestones related to the MRCT Center’s work in South-East Asia

Contact mrct@bwh.harvard.edu for more information.


Regulatory Reform in India

From 2013 to 2019, the MRCT Center worked closely with leaders in India to determine tractable solutions to regulatory reform issues, many of which deterred both for-profit and not-for-profit sponsors from conducting trials in the country. The MRCT Center worked with government officials, industry stakeholders, investigators, and others to develop alternative reforms that would not only reinvigorate the industry but also ensure the welfare of trial participants.

Key Milestones related to the MRCT Center’s work in India

  • July 2019: Published article with update about the evolving regulatory landscape for clinical trials in India
  • May 2019: The MRCT Center, in collaboration with Ropes & Gray LLP, hosted a special presentation and discussion with the Drugs Controller General of India to discuss the final New Drugs and Clinical Trials Rules, 2019, that were released in March, 2019 by India’s Ministry of Health and Family Welfare
  • March 2019: New rules released in India
  • December 2018: Published article about the evolving regulatory landscape in India
  • June 2018: Meetings with regulators, investigators, and industry in Delhi and Mumbai, India
  • March 2018: Submitted comments on updated draft rules in India
  • May 2017: Submitted comments on draft rules in India
  • March 2017: Additional meetings with representatives in India
  • March 2016: Meetings with regulators, investigators, representatives of industry, academia, non-profit organizations and patient advocacy groups in Delhi and Mumbai, India
  • October 2015: Meetings with regulators and thought leaders in Delhi, India
  • November 2014- January 2015: Publications in Financial ExpressBusiness Line, and Bloomberg BNA related to clinical trial regulations in India and proposed amendments to Drugs and Cosmetics Act.
  • January 2014: Output of January 20 and 21, 2014, Roundtable included a draft of detailed recommendations embodying the consensus of different stakeholders, including leading academicians, investigators, industry representatives, and government officials. This document also suggested additional issues that the Ministry of Health and Family Welfare, Government of India, may wish to reconsider when implementing clinical research regulatory reform in India.

    Contact mrct@bwh.harvard.edu for more information.


    Multi-Regional Clinical Trial Guidance in China

    From 2015 to 2017, in response to the China Food and Drug Administration (CFDA) issuing a Draft Guidance on Multi-Regional Clinical Trials that set forth requirements for clinical trials in China, the MRCT Center, in collaboration with Peking University, developed scientific principles upon which to ground decision-making for MRCTs.

    Key Milestones related to the MRCT Center’s work in China

    • March 2017: Patient-Centric Clinical Trials Conference in Shanghai
    • September 2016: China FDA Training at Yale University
    • May 2016:  Global Simultaneous Drug Development Workshop in Beijing
    • October 2015: Workshop in Beijing
    • June 2015:
      ◦ Roundtable in Shanghai
      ◦ Launched Consistency and Region Working Group
    • April 2015: First roundtable teleconference
    • March 2015: Launched project with Peking University

      Contact mrct@bwh.harvard.edu for more information.

      Project Resources

      Virtual DSMC Training in the Philippines

      In July 2022, the MRCT Center delivered a virtual training for members of the newly established Data Safety Monitoring Committee (DSMC) at the National Institutes of Health at the University of the Philippines in Manila, Philippines. The training described the purpose, functioning, roles and responsibilities of a DMSC and how to review study data in an ongoing manner to make decisions for study continuation.

      Self-assessed Competencies of Clinical Research Professionals and Recommendations for Further Education and Training

      Publication

      Published on: March 31, 2022

      Published in: Therapeutic Innovation & Regulatory Science

      The Joint Task Force for Clinical Trial Competency (JTF) conducted a global survey of clinical research professionals requesting respondents to self-assess their competencies in each of the eight domains of its Core Competency Framework version 3.1. The results were analyzed based upon role, years of experience, educational level, professional certification, institutional affiliation, and continuing education participation. Respondents with professional certification self-assessed their competencies in all domains at higher levels than those without professional certification. The survey demonstrated that irrespective of role, experience, or educational level, training curricula in both pre-professional and continuing professional education should include additional content relating to research methods, protocol design, medical product development and regulation, and data management and informatics. These results validate and extend the recommendations of a similar 2016 JTF and other surveys. We further recommend that clinical and translational research organizations and clinical sites assess training needs locally, using both subjective and objective measures of skill and knowledge.

      MRCT Center virtual training inspires students and lecturers in Indonesia

      In October 2021, the MRCT Center delivered seven modules as part of a 2-week clinical research virtual training to undergraduate and graduate students and lecturers participating in the Pfizer Biotech Fellowship program in Indonesia.

      The curriculum was designed to introduce students to the process of drug discovery and development in clinical research, as well as inspire them with guest speakers sharing their personal experience.

      Students who participated in the training were a part of 10 teams whose ideas have been selected for the development of health biotechnology ecosystem and policy environment. Participants will revise their concept papers based on what they learned during the training, and eventually three finalists will be chosen whose ideas propose solutions to some of the hottest issues in the biotechnology industry today.

      Read an article in The Jakarta Post about this training.

      MRCT Center conducts training with AVAREF

      In partnership with the African Vaccine Regulatory Forum (AVAREF), the MRCT Center completed the first comprehensive training of ethics committee chairs and members selected from across Africa. Conducted as an intensive virtual training, 35 matriculants, representing 18 countries, completed the training. This commitment, and the AVAREF-MRCT Center partnership, represents the importance of the ethical conduct of clinical research, of harmonizing the process of review, and of increasing efficiency and oversight while protecting the individual.

      MRCT Center Delivers Virtual Training in Algeria

      In May and early June 2021, the MRCT Center delivered nine modules as part of a 2-month clinical research virtual training to pharmacy and biotechnology engineering students attending the University of Algiers, and The School of Engineering & Biotechnology in Constantine, Algeria. The curriculum was designed to introduce students to the process of drug development and clinical research, including research and development, bioethics, good clinical practice, regulatory requirements, as well as post-market surveillance and real-world evidence.

      Capacity Building of Ethics Committees: an AVAREF-MRCT Center Collaboration

      The African Vaccine Regulatory Forum (AVAREF) and the MRCT Center are initiating a partnership focused on capacity building of ethics committee members. AVAREF and the MRCT Center will collaborate to create and deliver an ethics training course for AVAREF country-members’ National Ethics Committees (NECs)/Institutional Review Boards (IRBs).

      The purpose is to strengthen and augment the AVAREF country-member understanding of the ethical foundations of human participant research and their application to a variety of clinical research settings. An in-depth curriculum, offered virtually and leveraging cased-based learning, will focus on bioethics and best practices for the review and approval of clinical research, with the intention of enabling quality, efficiency, and the use of AVAREF standards and tools.

      Read article here.